{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:29:26Z","timestamp":1791217766674,"version":"4.1.0"},"reference-count":112,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ijantimicag.2015.06.005","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T14:10:16Z","timestamp":1435846216000},"page":"297-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":213,"title":["Use of colistin-containing products within the European Union and European Economic Area (EU\/EEA): development of resistance in animals and possible impact on human and animal health"],"prefix":"10.1016","volume":"46","author":[{"given":"Boudewijn","family":"Catry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cavaleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Baptiste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Grave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Grein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Jukes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto","family":"Liebana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Lopez","family":"Navas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Pelagia","family":"Magiorakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Angel Moreno","family":"Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5675-3931","authenticated-orcid":false,"given":"G\u00e9rard","family":"Moulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Mu\u00f1oz","family":"Madero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Constan\u00e7a Matias Ferreira","family":"Pomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mair","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satu","family":"Py\u00f6r\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja","family":"Rantala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1040-0249","authenticated-orcid":false,"given":"Modestas","family":"Ru\u017eauskas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Teale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric John","family":"Threlfall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"T\u00f6rneke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9419-9852","authenticated-orcid":false,"given":"Engeline","family":"van Duijkeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi Torren","family":"Edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0565","first-page":"457","article-title":"A new antibiotic \u2018colistin\u2019 produced by spore-forming soil bacteria","volume":"3","author":"Koyama","year":"1950","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0570","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-72-6-857","article-title":"Adverse effects of sodium colistimethate. Manifestations and specific reaction rates during 317 courses of therapy","volume":"72","author":"Koch-Weser","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0575","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0580","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJM196405142702002","article-title":"Polymyxin B and colistin. A critical comparison","volume":"270","author":"Nord","year":"1964","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0585","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.1969.03150240119022","article-title":"Colistimethate toxicity. Report of a fatal case in a previously healthy child","volume":"207","author":"Ryan","year":"1969","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0590","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","article-title":"Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance","volume":"18","author":"Magiorakos","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0595","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/QCO.0b013e328332e672","article-title":"Colistin in the 21st century","volume":"22","author":"Nation","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0600","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1086\/499406","article-title":"The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs","volume":"42","author":"Cosgrove","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0605","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ccc.2009.06.005","article-title":"Performance improvement in the management of sepsis","volume":"25","author":"Schorr","year":"2009","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0610","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/AAC.00035-06","article-title":"Colistin methanesulfonate is an inactive prodrug of colistin against Pseudomonas aeruginosa","volume":"50","author":"Bergen","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0615","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1473-3099(06)70580-1","article-title":"Colistin: the re-emerging antibiotic for multidrug-resistant Gram-negative bacterial infections","volume":"6","author":"Li","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0620","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1592\/phco.30.12.1279","article-title":"Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing","volume":"30","author":"Lim","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0625","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1183\/09031936.98.12030592","article-title":"Four years\u2019 experience of intravenous colomycin in an adult cystic fibrosis unit","volume":"12","author":"Ledson","year":"1998","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0630","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1592\/phco.31.9.912","article-title":"Revisiting \u2018older\u2019 antimicrobials in the era of multidrug resistance","volume":"31","author":"Pogue","year":"2011","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0635","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1177\/106002809102501101","article-title":"Toxicity of colistin in cystic fibrosis patients","volume":"25","author":"Bosso","year":"1991","journal-title":"DICP"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0640","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1177\/00912700122010537","article-title":"The pharmacokinetics of colistin in patients with cystic fibrosis","volume":"41","author":"Reed","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0645","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/00063198-200111000-00013","article-title":"The clinical use of colistin in patients with cystic fibrosis","volume":"7","author":"Beringer","year":"2001","journal-title":"Curr Opin Pulm Med"},{"issue":"503","key":"10.1016\/j.ijantimicag.2015.06.005_bib0650","first-page":"e1","article-title":"Systemic colistin use in children without cystic fibrosis: a systematic review of the literature","volume":"33","author":"Falagas","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0655","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/AAC.06426-11","article-title":"Application of a loading dose of colistin methanesulfonate in critically ill patients: population pharmacokinetics, protein binding, and prediction of bacterial kill","volume":"56","author":"Mohamed","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0660","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.01733-10","article-title":"Population pharmacokinetics of colistin methanesulfonate and formed colistin in critically ill patients from a multicenter study provide dosing suggestions for various categories of patients","volume":"55","author":"Garonzik","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0665","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cid\/cis909","article-title":"Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant Gram-negative bacteremia","volume":"56","author":"Vicari","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0670","first-page":"2311","article-title":"Pharmacokinetics of four different brands of colistimethate and formed colistin in rats","volume":"68","author":"He","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0675","unstructured":"European Pharmacopoeia Council of Europe, European Public Health Committee, Maisonneuve; 2013."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0680","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijantimicag.2012.10.005","article-title":"The novel polymyxin derivative NAB739 is remarkably less cytotoxic than polymyxin B and colistin to human kidney proximal tubular cells","volume":"41","author":"Vaara","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0685","doi-asserted-by":"crossref","first-page":"pii: 20316","DOI":"10.2807\/ese.17.46.20316-en","article-title":"The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use","volume":"17","author":"Zarb","year":"2012","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0690","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1586\/eri.12.138","article-title":"Bloodstream infections caused by carbapenemase-producing Klebsiella pneumoniae: a clinical perspective","volume":"10","author":"Daikos","year":"2012","journal-title":"Exp Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0695","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1586\/eri.12.162","article-title":"Treatment of carbapenem-resistant Klebsiella pneumoniae: the state of the art","volume":"11","author":"Petrosillo","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0700","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","article-title":"European network on carbapenemases. Rapid evolution and spread of carbapenemases among enterobacteriaceae in Europe","volume":"18","author":"Cant\u00f3n","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0705","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0710","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1473-3099(11)70056-1","article-title":"Metallo-\u03b2-lactamases: a last frontier for \u03b2-lactams?","volume":"11","author":"Cornaglia","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0715","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1473-3099(10)70278-4","article-title":"Global spread of New Delhi metallo-\u03b2-lactamase 1","volume":"10","author":"Bogaerts","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0720","doi-asserted-by":"crossref","first-page":"pii:19900","DOI":"10.2807\/ese.16.26.19900-en","article-title":"Rapid emergence of carbapenemase-producing enterobacteriaceae isolates in Belgium","volume":"16","author":"Huang","year":"2011","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0725","doi-asserted-by":"crossref","first-page":"pii:20525","DOI":"10.2807\/1560-7917.ES2013.18.28.20525","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries February 2013","volume":"18","author":"Glasner","year":"2013","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0730","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0735","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/AAC.06268-11","article-title":"Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens","volume":"56","author":"Qureshi","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0740","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/cid\/cit253","article-title":"Colistin and rifampicin compared with colistin alone for the treatment of serious infections due to extensively drug-resistant Acinetobacter baumannii: a multicenter, randomized clinical trial","volume":"57","author":"Durante-Mangoni","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0745","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ccc.2007.12.003","article-title":"Colistin and polymyxin B in critical care","volume":"24","author":"Michalopoulos","year":"2008","journal-title":"Crit Care Clin"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0750","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1093\/jac\/dkq360","article-title":"Randomized controlled trial of nebulized colistimethate sodium as adjunctive therapy of ventilator-associated pneumonia caused by Gram-negative bacteria","volume":"65","author":"Rattanaumpawan","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0755","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/ALN.0b013e31827515de","article-title":"Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii","volume":"117","author":"Lu","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0760","doi-asserted-by":"crossref","first-page":"E23","DOI":"10.1111\/1469-0691.12070","article-title":"SEERBIO-GRAB network. High rate of colistin resistance among patients with carbapenem-resistant Klebsiella pneumoniae infection accounts for an excess of mortality","volume":"19","author":"Capone","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0765","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jhin.2010.03.021","article-title":"Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 \u03b2-lactamase resistant to colistin","volume":"76","author":"Kontopoulou","year":"2010","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0770","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1128\/JCM.02301-09","article-title":"Risk factors and outcomes associated with acquisition of colistin-resistant KPC-producing Klebsiella pneumoniae: a matched case\u2013control study","volume":"48","author":"Zarkotou","year":"2010","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0775","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkr007","article-title":"Colistin heteroresistance in carbapenemase-producing Klebsiella pneumoniae","volume":"66","author":"Meletis","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0780","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00134-012-2761-3","article-title":"Colistin resistance in Gram-negative bacteria during prophylactic topical colistin use in intensive care units","volume":"39","author":"Oostdijk","year":"2013","journal-title":"Intensiv Care Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0785","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/AAC.02634-12","article-title":"Emergence of colistin resistance in enterobacteriaceae after the introduction of selective digestive tract decontamination in an intensive care unit","volume":"57","author":"Halaby","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0790","unstructured":"European Medicines Agency, European Surveillance of Veterinary Antimicrobial Consumption (EMA\/ESVAC). Sales of veterinary antimicrobial agents in 26 EU\/EEA countries in 2012. Fourth ESVAC report. European Medicines Agency. p. 1\u2013115. \u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2014\/10\/WC500175671.pdf \u3009; 2014 [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0795","first-page":"387","article-title":"Pharmacokinetics of colistin sulfate administered by intravenous and intramuscular routes in the calf [in French]","volume":"22","author":"Renard","year":"1991","journal-title":"Ann Rech Vet"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0800","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2746\/0425164044868350","article-title":"Polymyxin B protects horses against induced endotoxaemia in vivo","volume":"36","author":"Barton","year":"2004","journal-title":"Equine Vet J"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0805","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.cveq.2003.08.006","article-title":"Treatment of endotoxemia","volume":"19","author":"Moore","year":"2003","journal-title":"Vet Clin North Am Equine Pract"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0810","unstructured":"Official Journal of the European Union. Commission Regulation (EU) No 122\/2013 of 12 February 2013 amending Regulation (EC) No 1950\/2006 establishing, in accordance with Directive 2001\/82\/EC of the European Parliament and of the Council on the Community code relating to veterinary medicinal products, a list of substances essential for the treatment of Equidae. The European Commission.\u3008http:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2013:042:0001:0017:EN:PDF \u3009; 2013 [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0815","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.prevetmed.2005.10.003","article-title":"Quantification and evaluation of antimicrobial drug use in group treatments for fattening pigs in Belgium","volume":"74","author":"Timmerman","year":"2006","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0820","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.prevetmed.2012.03.001","article-title":"Prophylactic and metaphylactic antimicrobial use in Belgian fattening pig herds","volume":"106","author":"Callens","year":"2012","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0825","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/jac\/dkr570","article-title":"Prospective study on quantitative and qualitative antimicrobial and anti-inflammatory drug use in white veal calves","volume":"67","author":"Pardon","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0830","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijantimicag.2013.06.012","article-title":"What do we know about resistance to colistin in Enterobacteriaceae in avian and pig production in Europe?","volume":"42","author":"Kempf","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0835","series-title":"Antibioticumgebruik en antimicrobi\u00eble resistentie bij rundvee ontwikkeling van een surveillancesysteem op bedrijfsniveau [Use of antibiotics and antimicrobial resistance in cattle as evaluated by a herd-level surveillance system]","author":"Catry","year":"2007"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0840","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.prevetmed.2010.03.004","article-title":"Antimicrobial use in Swiss dairy farms: quantification and evaluation of data quality","volume":"95","author":"Men\u00e9ndez Gonz\u00e1lez","year":"2010","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0845","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/vr.100818","article-title":"Survey of quantitative antimicrobial consumption in two different pig finishing systems","volume":"171","author":"Moreno","year":"2012","journal-title":"Vet Rec"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0850","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.prevetmed.2012.02.020","article-title":"Antimicrobial use in Belgian broiler production","volume":"105","author":"Persoons","year":"2012","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0855","unstructured":"MARAN 2009. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands in 2009. \u3008http:\/\/edepot.wur.nl\/165958\u3009; 2009 [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0860","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jchromb.2012.04.028","article-title":"Analysis of colistin A and B in fishery products by ultra performance liquid chromatography with positive electrospray ionization tandem mass spectrometry","volume":"899","author":"Xu","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0865","unstructured":"DANMAP 2011, Use of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Statens Serum Institut\/National Veterinary Institute\/National Food Institute. \u3008http:\/\/www.danmap.org\/Downloads\/\u223c\/media\/Projekt%20sites\/Danmap\/DANMAP%20reports\/Danmap_2011.ashx\u3009; 2011 [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0870","unstructured":"European Medicines Agency, Committee for Medicinal Products for Veterinary Use (EMA\/CVMP). Opinion following an Article 35 referral for veterinary medicinal formulations containing colistin at 2 000 000 IU per ml and intended for administration in drinking water to food producing species. EMA\/CVMP. \u3008http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Referrals_document\/Colistin_35\/WC500093733.pdf.\u3009; 2010 [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0875","doi-asserted-by":"crossref","first-page":"4425","DOI":"10.1021\/bi00587a024","article-title":"Interaction of divalent cations and polymyxin B with lipopolysaccharide","volume":"18","author":"Schindler","year":"1979","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0880","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/jac\/dkr239","article-title":"Contemporary activity of colistin and polymyxin B against a worldwide collection of Gram-negative pathogens: results from the SENTRY Antimicrobial Surveillance Program (2006\u201309)","volume":"66","author":"Gales","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0885","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1093\/jac\/dkn009","article-title":"Potential for underdosing and emergence of resistance in Acinetobacter baumannii during treatment with colistin","volume":"61","author":"David","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0890","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0895","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ijantimicag.2007.12.009","article-title":"Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections","volume":"31","author":"McKinnon","year":"2008","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2110-5820-1-30","article-title":"Colistin: recent data on pharmacodynamics properties and clinical efficacy in critically ill patients","volume":"1","author":"Michalopoulos","year":"2011","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0905","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00006-08","article-title":"Polymyxins revisited","volume":"21","author":"Landman","year":"2008","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0910","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/AAC.30.6.964","article-title":"Association between colistin resistance and broad-spectrum recipient deficiency in Klebsiella pneumoniae","volume":"30","author":"Lamousin-White","year":"1986","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0915","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/infdis\/138.3.293","article-title":"Analysis of increasing antibiotic resistance of Klebsiella pneumoniae relative to changes in chemotherapy","volume":"138","author":"O\u2019Callaghan","year":"1978","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0920","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1128\/AAC.05829-11","article-title":"PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients","volume":"56","author":"Moskowitz","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0925","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2958.1995.tb02299.x","article-title":"Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A","volume":"16","author":"Nummila","year":"1995","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0930","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1128\/JB.186.2.575-579.2004","article-title":"A two-component regulatory system of Pseudomonas aeruginosa that modulates resistance to cationic antimicrobial peptides and addition of aminoarabinose to lipid A","volume":"186","author":"Moskowitz","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0935","first-page":"329","article-title":"4-Amino-4-deoxy-l-arabinose in LPS of enterobacterial R-mutants and its possible role for their polymyxin reactivity","volume":"8","author":"Boll","year":"1994","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0940","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1128\/AAC.00242-10","article-title":"Adaptive resistance to the \u2018last hope\u2019 antibiotics polymyxin B and colistin in Pseudomonas aeruginosa is mediated by the novel two-component regulatory system ParR\u2013ParS","volume":"54","author":"Fernandez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0945","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00021-13","article-title":"Clinical use of colistin induces cross-resistance to host antimicrobials in Acinetobacter baumannii","volume":"4","author":"Napier","year":"2013","journal-title":"MBio"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0950","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/AAC.00079-11","article-title":"Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system","volume":"55","author":"Beceiro","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0955","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1093\/jac\/dkr265","article-title":"False extended-spectrum \u03b2-lactamase phenotype in clinical isolates of Escherichia coli associated with increased expression of OXA-1 or TEM-1 penicillinases and loss of porins","volume":"66","author":"Beceiro","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0960","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1128\/JB.00308-12","article-title":"Molecular basis of Yersinia enterocolitica temperature-dependent resistance to antimicrobial peptides","volume":"194","author":"Rein\u00e9s","year":"2012","journal-title":"J Bacteriol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0965","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1126\/science.276.5310.250","article-title":"Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP\u2013phoQ","volume":"276","author":"Guo","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0970","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.vetmic.2011.12.018","article-title":"Systematic mutation analysis of two-component signal transduction systems reveals EsrA\u2013EsrB and PhoP\u2013PhoQ as the major virulence regulators in Edwardsiella tarda","volume":"157","author":"Lv","year":"2012","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0975","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1365-2958.2000.01956.x","article-title":"Temperature-regulated efflux pump\/potassium antiporter system mediates resistance to cationic antimicrobial peptides in Yersinia","volume":"37","author":"Bengoechea","year":"2000","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0980","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1101\/gr.154328.112","article-title":"Genomic insights into the fate of colistin resistance and Acinetobacter baumannii during patient treatment","volume":"23","author":"Snitkin","year":"2013","journal-title":"Genome Res"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0985","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0030-5898(20)31668-0","article-title":"Bacterial resistance","volume":"22","author":"Gentry","year":"1991","journal-title":"Orthop Clin North Am"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0990","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1128\/JCM.02574-12","article-title":"Longitudinal analyses of gut mucosal microbiotas in ulcerative colitis in relation to patient age and disease severity and duration","volume":"51","author":"Fite","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib0995","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1128\/AAC.02499-12","article-title":"Bis-(3\u2032\u20135\u2032)-cyclic dimeric GMP regulates antimicrobial peptide resistance in Pseudomonas aeruginosa","volume":"57","author":"Chua","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1000","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4103\/0255-0857.83905","article-title":"Polymyxins: antimicrobial susceptibility concerns and therapeutic options","volume":"29","author":"Balaji","year":"2011","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1005","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/JCM.39.1.183-190.2001","article-title":"Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines","volume":"39","author":"Gales","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1010","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1128\/AAC.01406-06","article-title":"Comparative evaluation of the VITEK 2, disk diffusion, Etest, broth microdilution, and agar dilution susceptibility testing methods for colistin in clinical isolates, including heteroresistant Enterobacter cloacae and Acinetobacter baumannii strains","volume":"51","author":"Lo-Ten-Foe","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1015","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.vetmic.2010.01.010","article-title":"Disk prediffusion is a reliable method for testing colistin susceptibility in porcine E. coli strains","volume":"144","author":"Boyen","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1020","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1128\/JCM.03385-12","article-title":"Colistin MIC variability by method for contemporary clinical isolates of multidrug-resistant Gram-negative bacilli","volume":"51","author":"Hindler","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1025","unstructured":"European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 3.1, 2013. EUCAST, \u3008http:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/Breakpoint_table_v_3.1.pdf.\u3009; 2013. [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1030","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1089\/fpd.2011.1015","article-title":"Tentative colistin epidemiological cut-off value for Salmonella spp","volume":"9","author":"Agerso","year":"2012","journal-title":"Foodborne Pathog Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1035","unstructured":"European Commission Commission implementing decision (2013\/652\/EU) on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria. Official Journal of the European Union; 2013."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1040","unstructured":"European Food Safety Authority, European Centre for Disease Prevention and Control (EFSA\/ECDC). The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2010. EFSA\/ECDC; 2012."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1045","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1128\/JCM.00313-13","article-title":"Next-generation antimicrobial susceptibility testing","volume":"51","author":"van Belkum","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1050","unstructured":"MARAN 2012. Monitoring of antimicrobial resistance and antibiotic usage in animals in the Netherlands, \u3008http:\/\/www.wageningenur.nl\/upload_mm\/f\/2\/8\/39a1adb8-497e-49d6-b696-9401f23089f5_MARAN2012.pdf.\u3009; 2012 [accessed 09.06.15]."},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1055","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1863-2378.2007.01071.x","article-title":"Antimicrobial resistance in bacteria from Swiss veal calves at slaughter","volume":"54","author":"Di Labio","year":"2007","journal-title":"Zoonoses Public Health"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1060","first-page":"18","article-title":"Antimicrobial resistance transmissible from food animals to humans\u2014a risk profile","author":"Geenen","year":"2011","journal-title":"Dutch Soc Vet Epidemiol Econ"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1065","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/AAC.05387-11","article-title":"Antimicrobial susceptibilities of Aeromonas strains isolated from clinical and environmental sources to 26 antimicrobial agents","volume":"56","author":"Aravena-Roman","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1070","first-page":"pii:e00113","article-title":"Draft genome sequences of two multidrug resistant Klebsiella pneumoniae ST258 isolates resistant to colistin","volume":"1","author":"Comandatore","year":"2013","journal-title":"Genome Announc"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1128\/JCM.02234-12","article-title":"Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract","volume":"51","author":"Brink","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1080","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2334-13-58","article-title":"OXA-181-producing Klebsiella pneumoniae establishing in Singapore","volume":"13","author":"Balm","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1085","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/infdis\/jit293","article-title":"Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections","volume":"208","author":"Lesho","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1090","series-title":"Proceedings of the 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","author":"Del Bono","year":"2013"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1095","series-title":"Proceedings of the First International Conference on Polymyxins","first-page":"1865","article-title":"In the era of polymyxins use: emergence of colistin resistance in Klebsiella pneumoniae","author":"Galani","year":"2013"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1100","series-title":"Proceedings of the 23rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID)","article-title":"Colistin-resistance development in Acinetobacter baumannii during colistin treatment associated with lipopolysaccharide (LPS) modification, impaired biofilm production and colistin-mediated cell death","author":"Dafopoulou","year":"2013"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1105","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/AAC.01020-10","article-title":"Outbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, Michigan","volume":"55","author":"Marchaim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1110","doi-asserted-by":"crossref","first-page":"pii:20248","DOI":"10.2807\/ese.17.33.20248-en","article-title":"Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011","volume":"17","author":"Mammina","year":"2012","journal-title":"Eurosurveillance"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1115","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.prevetmed.2012.09.007","article-title":"Reply to Letter to the Editor by Moore and Elborn (2012) concerning the manuscript \u2018Prophylactic and metaphylactic antimicrobial use in Belgian fattening pig herds\u2019 by B Callens et al. (2012)","volume":"107","author":"Callens","year":"2012","journal-title":"Prev Vet Med"},{"key":"10.1016\/j.ijantimicag.2015.06.005_bib1120","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1093\/jac\/dkt416","article-title":"Selective decontamination of the oropharynx and the digestive tract, and antimicrobial resistance: a 4 year ecological study in 38 intensive care units in The Netherlands","volume":"69","author":"Houben","year":"2014","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857915002228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T20:04:09Z","timestamp":1652731449000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857915002228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":112,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0924857915002228"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.06.005","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of colistin-containing products within the European Union and European Economic Area (EU\/EEA): development of resistance in animals and possible impact on human and animal health","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2015.06.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}